Understanding RAB39B-mediated Parkinson's disease [ 2018 - 2020 ]

Research Grant

Researchers: A/Pr Paul Lockhart (Principal investigator) ,  A/Pr David Finkelstein ,  A/Pr Mirella Dottori ,  Prof Martin Delatycki ,  Prof Matthew Farrer

Brief description Parkinson’s disease (PD) is a complex neurological condition affecting 100,000 Australians. The primary clinical features of PD result from the selective loss of a specific type of neuron. It is currently unclear why these neurons are preferentially lost. We have identified a novel gene that causes early onset PD. This study will characterise the gene and determine the underlying disease mechanism. These studies will enable the development of novel therapies for treating PD.

Funding Amount $AUD 734,730.20

Funding Scheme Project Grants

Notes Standard Project Grant